| Post |
| Pre |
| LA |
|---|
| 8.8 |
| 4.5 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 2.5 | 110.2 | 66.2 | - | - | - | 179 |
| - | - | - | - | - | 17 | 8 | 2 | - | - | 27 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 55.5 |
| 8.2 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 0.7 |
| 0.3 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 711 | 67.5% | -2.80 | 102 | 48.3% |
| AME(R) | 222 | 21.1% | -2.75 | 33 | 15.6% |
| Optic-unspecified(R) | 84 | 8.0% | -0.56 | 57 | 27.0% |
| LA(R) | 35 | 3.3% | -0.96 | 18 | 8.5% |
| CentralBrain-unspecified | 2 | 0.2% | -1.00 | 1 | 0.5% |
| upstream partner | # | NT | conns Lat3 | % In | CV |
|---|---|---|---|---|---|
| aMe17a (R) | 1 | unc | 39.5 | 15.2% | 0.0 |
| MeVP45 (R) | 1 | ACh | 23.5 | 9.0% | 0.0 |
| MeVC3 (L) | 1 | ACh | 18.2 | 7.0% | 0.0 |
| Lat3 (R) | 4 | unc | 18.2 | 7.0% | 0.4 |
| Cm34 (R) | 1 | Glu | 15.5 | 6.0% | 0.0 |
| aMe12 (R) | 2 | ACh | 14.8 | 5.7% | 0.3 |
| aMe26 (R) | 3 | ACh | 10 | 3.8% | 0.3 |
| Cm31b (R) | 1 | GABA | 9 | 3.5% | 0.0 |
| aMe2 (R) | 4 | Glu | 8 | 3.1% | 0.5 |
| Mi10 (R) | 17 | ACh | 8 | 3.1% | 0.6 |
| MeVP1 (R) | 7 | ACh | 7.5 | 2.9% | 0.6 |
| MeVC20 (R) | 2 | Glu | 5.2 | 2.0% | 0.2 |
| aMe22 (R) | 1 | Glu | 4.2 | 1.6% | 0.0 |
| CL125 (R) | 2 | Glu | 4.2 | 1.6% | 0.3 |
| 5thsLNv_LNd6 (R) | 2 | ACh | 4.2 | 1.6% | 0.1 |
| aMe17b (R) | 2 | GABA | 4 | 1.5% | 0.6 |
| Cm1 (R) | 9 | ACh | 3.8 | 1.4% | 0.6 |
| Cm5 (R) | 10 | GABA | 3.5 | 1.3% | 0.7 |
| Mi15 (R) | 9 | ACh | 3 | 1.2% | 0.5 |
| Cm20 (R) | 5 | GABA | 3 | 1.2% | 0.6 |
| Dm2 (R) | 7 | ACh | 2.8 | 1.1% | 0.5 |
| Lat1 (R) | 2 | unc | 2.5 | 1.0% | 0.2 |
| MeTu1 (R) | 7 | ACh | 2.5 | 1.0% | 0.3 |
| Cm8 (R) | 6 | GABA | 2.5 | 1.0% | 0.6 |
| Cm24 (R) | 4 | Glu | 2 | 0.8% | 0.6 |
| Cm3 (R) | 6 | GABA | 2 | 0.8% | 0.4 |
| Tm29 (R) | 4 | Glu | 1.8 | 0.7% | 0.5 |
| MeVC27 (L) | 3 | unc | 1.8 | 0.7% | 0.5 |
| aMe4 (R) | 4 | ACh | 1.5 | 0.6% | 0.3 |
| Cm17 (R) | 2 | GABA | 1.2 | 0.5% | 0.6 |
| aMe12 (L) | 2 | ACh | 1.2 | 0.5% | 0.2 |
| DNpe053 (R) | 1 | ACh | 1.2 | 0.5% | 0.0 |
| Cm31a (R) | 2 | GABA | 1.2 | 0.5% | 0.2 |
| OA-AL2i4 (R) | 1 | OA | 1.2 | 0.5% | 0.0 |
| MeTu3c (R) | 4 | ACh | 1.2 | 0.5% | 0.3 |
| OA-AL2i3 (R) | 2 | OA | 1 | 0.4% | 0.5 |
| aMe5 (R) | 3 | ACh | 1 | 0.4% | 0.4 |
| aMe1 (R) | 2 | GABA | 1 | 0.4% | 0.5 |
| Cm6 (R) | 3 | GABA | 1 | 0.4% | 0.4 |
| Dm9 (R) | 4 | Glu | 1 | 0.4% | 0.0 |
| Tm34 (R) | 1 | Glu | 0.8 | 0.3% | 0.0 |
| MeVP33 (R) | 1 | ACh | 0.8 | 0.3% | 0.0 |
| MeVP12 (R) | 2 | ACh | 0.8 | 0.3% | 0.3 |
| Cm21 (R) | 1 | GABA | 0.8 | 0.3% | 0.0 |
| DNpe053 (L) | 1 | ACh | 0.8 | 0.3% | 0.0 |
| MeVC_unclear (R) | 1 | Glu | 0.8 | 0.3% | 0.0 |
| Cm19 (R) | 2 | GABA | 0.8 | 0.3% | 0.3 |
| aMe30 (R) | 2 | Glu | 0.8 | 0.3% | 0.3 |
| Cm30 (R) | 1 | GABA | 0.8 | 0.3% | 0.0 |
| Lat5 (R) | 1 | unc | 0.8 | 0.3% | 0.0 |
| Cm29 (R) | 2 | GABA | 0.8 | 0.3% | 0.3 |
| Cm23 (R) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| aMe9 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| Cm16 (R) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| MeVC5 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| Cm7 (R) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| SMP217 (R) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| aMe6b (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| Cm25 (R) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 0.5 | 0.2% | 0.0 |
| Cm9 (R) | 2 | Glu | 0.5 | 0.2% | 0.0 |
| Lat2 (R) | 1 | unc | 0.5 | 0.2% | 0.0 |
| Tm5c (R) | 2 | Glu | 0.5 | 0.2% | 0.0 |
| Dm8b (R) | 2 | Glu | 0.5 | 0.2% | 0.0 |
| MeVP7 (R) | 2 | ACh | 0.5 | 0.2% | 0.0 |
| MeLo6 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP48 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP30 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| aMe3 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVPMe6 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Cm12 (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| MeVP2 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Dm8a (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| aMe9 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVPMe9 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP9 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP41 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP56 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeVP29 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LT58 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| R1-R6 | 1 | HA | 0.2 | 0.1% | 0.0 |
| Dm-DRA1 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeTu3b (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| MeVC10 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| Mi19 (R) | 1 | unc | 0.2 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Lat3 | % Out | CV |
|---|---|---|---|---|---|
| Lat3 (R) | 4 | unc | 18.2 | 21.3% | 0.4 |
| Cm9 (R) | 11 | Glu | 4.2 | 5.0% | 0.3 |
| Cm35 (R) | 1 | GABA | 3 | 3.5% | 0.0 |
| Cm34 (R) | 1 | Glu | 2.8 | 3.2% | 0.0 |
| aMe10 (R) | 2 | ACh | 2.5 | 2.9% | 0.2 |
| Cm11c (R) | 5 | ACh | 2.5 | 2.9% | 0.4 |
| aMe15 (R) | 1 | ACh | 2 | 2.3% | 0.0 |
| aMe4 (R) | 5 | ACh | 2 | 2.3% | 0.5 |
| MeVP59 (R) | 1 | ACh | 1.8 | 2.0% | 0.0 |
| R1-R6 | 5 | HA | 1.8 | 2.0% | 0.3 |
| Cm20 (R) | 4 | GABA | 1.5 | 1.7% | 0.3 |
| aMe26 (R) | 3 | ACh | 1.5 | 1.7% | 0.4 |
| Cm10 (R) | 3 | GABA | 1.2 | 1.5% | 0.6 |
| MeVP45 (R) | 1 | ACh | 1.2 | 1.5% | 0.0 |
| L1 (R) | 2 | Glu | 1.2 | 1.5% | 0.6 |
| Cm3 (R) | 4 | GABA | 1.2 | 1.5% | 0.3 |
| MeTu1 (R) | 5 | ACh | 1.2 | 1.5% | 0.0 |
| Cm14 (R) | 4 | GABA | 1.2 | 1.5% | 0.3 |
| MeVPMe5 (L) | 3 | Glu | 1 | 1.2% | 0.4 |
| Tm5c (R) | 3 | Glu | 1 | 1.2% | 0.4 |
| Dm2 (R) | 4 | ACh | 1 | 1.2% | 0.0 |
| MeLo6 (R) | 4 | ACh | 1 | 1.2% | 0.0 |
| MeTu3b (R) | 4 | ACh | 1 | 1.2% | 0.0 |
| Cm31b (R) | 1 | GABA | 0.8 | 0.9% | 0.0 |
| Cm16 (R) | 2 | Glu | 0.8 | 0.9% | 0.3 |
| Cm25 (R) | 2 | Glu | 0.8 | 0.9% | 0.3 |
| Lat2 (R) | 1 | unc | 0.8 | 0.9% | 0.0 |
| Cm8 (R) | 2 | GABA | 0.8 | 0.9% | 0.3 |
| MeVPaMe2 (R) | 1 | Glu | 0.8 | 0.9% | 0.0 |
| Mi15 (R) | 3 | ACh | 0.8 | 0.9% | 0.0 |
| aMe5 (R) | 3 | ACh | 0.8 | 0.9% | 0.0 |
| MeVPMe5 (R) | 3 | Glu | 0.8 | 0.9% | 0.0 |
| MeVP9 (R) | 3 | ACh | 0.8 | 0.9% | 0.0 |
| Lat5 (R) | 1 | unc | 0.5 | 0.6% | 0.0 |
| TmY5a (R) | 1 | Glu | 0.5 | 0.6% | 0.0 |
| MeVPLp2 (R) | 1 | Glu | 0.5 | 0.6% | 0.0 |
| aMe6b (R) | 1 | ACh | 0.5 | 0.6% | 0.0 |
| Cm5 (R) | 2 | GABA | 0.5 | 0.6% | 0.0 |
| Mi10 (R) | 2 | ACh | 0.5 | 0.6% | 0.0 |
| MeTu3c (R) | 2 | ACh | 0.5 | 0.6% | 0.0 |
| Cm24 (R) | 2 | Glu | 0.5 | 0.6% | 0.0 |
| aMe3 (R) | 1 | Glu | 0.5 | 0.6% | 0.0 |
| MeVC8 (L) | 1 | ACh | 0.5 | 0.6% | 0.0 |
| Cm30 (R) | 2 | GABA | 0.5 | 0.6% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.5 | 0.6% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.5 | 0.6% | 0.0 |
| Cm12 (R) | 2 | GABA | 0.5 | 0.6% | 0.0 |
| Cm11a (R) | 2 | ACh | 0.5 | 0.6% | 0.0 |
| Cm21 (R) | 2 | GABA | 0.5 | 0.6% | 0.0 |
| Cm17 (R) | 2 | GABA | 0.5 | 0.6% | 0.0 |
| aMe12 (R) | 2 | ACh | 0.5 | 0.6% | 0.0 |
| l-LNv (R) | 2 | unc | 0.5 | 0.6% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 0.5 | 0.6% | 0.0 |
| Tm5b (R) | 2 | ACh | 0.5 | 0.6% | 0.0 |
| Lat1 (R) | 2 | unc | 0.5 | 0.6% | 0.0 |
| Tm12 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| Tm39 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVP12 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVP10 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVC_unclear (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| HBeyelet (R) | 1 | HA | 0.2 | 0.3% | 0.0 |
| aMe23 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVPMe9 (L) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| Cm32 (R) | 1 | GABA | 0.2 | 0.3% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVC27 (L) | 1 | unc | 0.2 | 0.3% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 0.2 | 0.3% | 0.0 |
| Cm6 (R) | 1 | GABA | 0.2 | 0.3% | 0.0 |
| Mi14 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| Dm8b (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| Cm7 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVP35 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVP30 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVP29 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVC22 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| Cm1 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| TmY18 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| T2a (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeLo3b (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| TmY21 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| aMe6a (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVP43 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVP24 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| L4 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MeLo7 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| Tm37 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVP16 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| Cm23 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVP34 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| CL125 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |
| MeVP63 (R) | 1 | GABA | 0.2 | 0.3% | 0.0 |
| MeVP42 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| l-LNv (L) | 1 | unc | 0.2 | 0.3% | 0.0 |
| MeVP49 (R) | 1 | Glu | 0.2 | 0.3% | 0.0 |